Off-the-shelf cell therapies for liver disease
Shyft Score
Directory quality rating
Our take
Request a demo to evaluate Hepatx for your team.
See how Hepatx fits your stackBenefits
Avoid lengthy organ transplant waiting lists and procedures
Monitor patient recovery in real-time with integrated analytics
Streamline patient management with automated EHR integration
Ensure full regulatory compliance with automated tracking and reporting
About
HepaTx is developing new types of treatments based on stem cells to bring therapies to patients with late-stage liver disease as an alternative to liver transplant. Using regenerative medicine technologies, they aim to address the critical shortage of liver transplants, where only 1 in 33 patients receive the life-saving procedure despite $8.5 billion spent annually on patient care.
regenerative medicine-based therapies
stem cell treatments
scalable manufacturing process
alternative to liver transplant
Use cases
Patients with end-stage liver disease can avoid transplant waitlists
Hospitals reduce costs by eliminating transplant surgery and recovery
Insurers lower expenses by avoiding high-cost transplant procedures
Best for
Pricing
Hepatx starts at $99/mo
Starting at $99/mo
Ecosystem
MCP servers, AI skills, and integrations that work with Hepatx
FAQs
Common questions about Hepatx and its capabilities
Hepatx offers advanced infusion technology for organ replacement, real-time patient monitoring, EHR integration, patient management, and regulatory compliance tracking. These features streamline patient care and improve outcomes for hospitals and healthcare providers.
Our team can help you integrate Hepatx with your existing tools and build custom automation workflows.
Pulse delivers product-specific AI insights every week. Free.
Explore
Alternatives, related tools, and resources for Hepatx
Our free scan analyzes your website, detects your tools, and shows gaps in your AI readiness.